A fast and simple workflow for surrogate peptide bioanalysis: NISTmAb case study

Importance of the Topic

Early-stage quantitative bioanalysis of monoclonal antibodies (mAbs) is critical for drug discovery and development. Fast, robust, and sensitive workflows drive decision making, reduce sample volume requirements, and accelerate ADME screening for biotherapeutics.

Objectives and Study Overview

This study evaluated a simplified immunoaffinity–tryptic digestion–LC-MS/MS workflow for chimeric and humanized mAbs in rat plasma. The aim was to develop a generic protocol delivering high throughput (96 samples in under four hours), single-digit accuracy and precision, and a linear quantitative range of 10–10 000 ng/mL from only 50 µL of sample.

Methodology and Instrumentation

A three-step, single-well protocol was implemented:

• Affinity capture: Anti-human IgG Fc antibody was crosslinked to SMART Digest IA Protein G magnetic beads. Rat plasma samples spiked with NISTmAb standards and QC levels were incubated with beads (120 min at RT) and washed four times with buffer.
• On-bead digestion: Tryptic digestion was performed directly on beads at 70 °C, 1400 rpm for 60 min using heat-stable SMART Digest reagents.
• LC-MS/MS analysis: 20 µL injections on a Vanquish Horizon UHPLC with Acclaim 120 C18 column (50 × 2.1 mm, 2.2 µm). A 0.1% formic acid water/acetonitrile gradient at 0.5 mL/min separated peptides. Detection used a TSQ Quantiva triple quadrupole in positive mode monitoring transitions for Fc-derived surrogate peptides VVSVLTVLHQDWLNGK and TTPPVLDSDGSFFLYSK with stable-isotope-labeled IgG as internal standard.

Main Results and Discussion

The workflow achieved:

• Linear response (r² ≥ 0.998) over 10–10 000 ng/mL.
• Mean accuracy between −6% and +9%, precision ≤ 9% RSD across QC levels (50, 500, 5000 ng/mL).
• LLOQ of 10 ng/mL from 50 µL sample with excellent signal-to-noise.
• Recovery: 97% from water (1.4% RSD) and 73% from plasma (8.6% RSD).
• Matrix effects: 6–11% signal suppression in rat plasma.

Benefits and Practical Applications

The protocol significantly reduces preparation time compared to traditional in-solution digestions, lowers sample and reagent consumption, and simplifies handling. Its generic design enables rapid transfer between mAbs, making it ideal for CROs and pharmaceutical labs generating early PK data.

Future Trends and Opportunities

Emerging directions include:

• Automation of bead handling and digestion to further increase throughput.
• Integration of more selective variable-region peptides and highly specific capture antibodies for human matrices.
• Adoption of multiplexed workflows for simultaneous quantitation of multiple biotherapeutics.
• Enhanced data processing pipelines with LIMS connectivity for streamlined reporting.

Conclusion

This case study demonstrates a fast, reproducible, and sensitive immunoaffinity capture plus on-bead digestion workflow for surrogate peptide quantitation of mAbs. The method meets stringent accuracy and precision requirements while supporting high throughput and minimal sample volume, and is readily adaptable to diverse biotherapeutic targets.

Instrumentation

• SMART Digest IA Protein G magnetic kit
• Thermo Scientific Vanquish Horizon UHPLC system
• Thermo Scientific Acclaim 120 C18 column (50 × 2.1 mm, 2.2 µm)
• Thermo Scientific TSQ Quantiva triple quadrupole mass spectrometer
• Thermo Scientific Virtuoso vials and thermal mixer

References

1. Kaitin, K.I. Obstacles and opportunities in new drug development. Clinical Pharmacology & Therapeutics 2008, 83, 210–212.
2. Thermo Fisher Scientific. SMART Digest ImmunoAffinity Kit User Manual, Version 1, Revision A.
3. Thermo Fisher Scientific. Application Note 21504: Fast Digestion Method Optimization.
4. Thermo Fisher Scientific. Using Innovative Trypsin Technology, 2016.
5. Thermo Fisher Scientific. Acclaim 120 C18 columns product sheet.